Center Book Partners LP Xeris Biopharma Holdings, Inc. Transaction History
Center Book Partners LP
- $1.54 Billion
- Q3 2024
A detailed history of Center Book Partners LP transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Center Book Partners LP holds 3,482,006 shares of XERS stock, worth $11.7 Million. This represents 0.64% of its overall portfolio holdings.
Number of Shares
3,482,006
Previous 1,465,875
137.54%
Holding current value
$11.7 Million
Previous $3.3 Million
200.88%
% of portfolio
0.64%
Previous 0.22%
Shares
4 transactions
Others Institutions Holding XERS
# of Institutions
142Shares Held
59.9MCall Options Held
148KPut Options Held
45.7K-
Black Rock Inc. New York, NY10.3MShares$34.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$26.2 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$17.2 Million62.59% of portfolio
-
Geode Capital Management, LLC Boston, MA3.33MShares$11.2 Million0.0% of portfolio
-
State Street Corp Boston, MA3.2MShares$10.8 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $458M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...